CD274 and non-small cell lung carcinoma: Regarding PD-L1, it was reported that the correlation between the serum levels of soluble form and the tumor PD-L1 expression was weak in patients with NSCLC (10), thus soluble forms of immune checkpoint molecules have potential to be a biomarker independent of those of membranous expression.